UK experience of treosulfan-based conditioning regimens in children with primary immunodeficiency

被引：0
|
作者：
Slatter, M. [1 ]
Rao, K. [2 ]
Amrolia, P. [2 ]
Flood, T.
Abinun, M. [1 ]
Cant, A. [1 ]
Hambleton, S. [3 ]
Goulden, N. [2 ]
Davies, G. [2 ]
Qasim, W. [2 ]
Gasper, H. B. [2 ]
Gennery, A. [1 ]
Veys, P. [2 ]
机构：
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[2] Great Ormond St Hosp NHS Trust, London, England
[3] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [21] Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies
    Haskologlu, Sule
    Bal, Sevgi Kostel
    Islamoglu, Candan
    Altun, Demet
    Kendirli, Tanil
    Dogu, Esin Figen
    Ikinciogullari, Aydan
    PEDIATRIC TRANSPLANTATION, 2018, 22 (07)
  • [22] Successful treosulfan-based conditioning in patients with inborn errors: a single-centre experience
    Comoli, P.
    Poddighe, D.
    Calafiore, L.
    Bergami, E.
    Pozzi, M.
    Visconti, C.
    Rundo, B.
    Guerini, P.
    Ottonello, G.
    Zavras, N.
    Giorgiani, G.
    Bonetti, F.
    Zecca, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S159 - S159
  • [23] Successful allogeneic HSCT after treosulfan-based conditioning in two children with PNH: single-center experience
    Pieczonka, A.
    Skalska-Sadowska, J.
    Sobkowiak-Sobierajska, A.
    Wachowiak-Szajdak, K.
    Tomaszewska, R.
    Szczepanski, T.
    Wachowiak, J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S244 - S244
  • [24] Late effects after treosulfan-based conditioning for allogeneic HSCT in children with hematologic malignancies: a single-center experience
    Skvortsova, Yulia
    Shipitsina, Irina
    Balashov, Dmitrij
    Trakhtman, Pavel
    Blagonravova, Oksana
    Persiantseva, Marina
    Skorobogatova, Elena
    Papusha, Lyudmila
    Gutovskaya, Elena
    Shelikhova, Larisa
    Kurnikova, Elena
    Voronin, Kirill
    Maschan, Michail
    Maschan, Alexej
    BONE MARROW TRANSPLANTATION, 2018, 53 : 345 - 346
  • [25] Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis
    Atagunduz, Isik Kaygusuz
    Klyuchnikov, Evgeny
    Wolschke, Christine
    Janson, Dietlinde
    Heidenreich, Silke
    Christopeit, Maximilian
    Ayuk, Francis
    Kroeger, Nicolaus
    CANCERS, 2020, 12 (11) : 1 - 11
  • [26] Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience (vol 128, pg 440, 2016)
    Morillo-Gutierrez, B.
    Beier, R.
    Rao, K.
    BLOOD, 2016, 128 (21) : 2585 - 2585
  • [27] Is Treosulfan-Based Conditioning Attractive as a Reduced-Intensity Conditioning Regimen in Korea?
    Kim, Se Hyung
    Ji, Young Sok
    Yun, Jina
    Choi, Seong Hyeok
    Lim, Sung Hee
    Kim, Chan Kyu
    Park, Seong Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (36)
  • [28] New treosulfan-based conditioning regimens including epigenetic agents in patients with very high-risk neuroblastoma
    Dolgopolov, Igor
    Rubanskaya, Marina
    Boyarshinov, Vasily
    Subbotina, Natalia
    Dajlidite, Vida
    Tukhvatulina, Maria
    Mentkevich, Georgy
    BONE MARROW TRANSPLANTATION, 2019, 54 : 532 - 533
  • [29] Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in paediatric non-malignant diseases
    Elbahy, Samar
    Bonney, Denise
    Campbell, Helen
    Khaled, Tasneem
    Deambrosis, David
    Wynn, Robert
    BONE MARROW TRANSPLANTATION, 2019, 54 : 208 - 209
  • [30] Treosulfan-based reduced-intensity hematopoietic stem cell transplantation in adults with primary immunodeficiency
    Via, V. Dalla
    Stelmes, A.
    Halter, J.
    Recher, M.
    Heim, D.
    Passweg, J.
    Medinger, M.
    van den Berg, J.
    SWISS MEDICAL WEEKLY, 2021, 151 : 30 - 30
12345